Frontlight ResearchEarly access
Trial site
Haematologie und Onkologie Muenchen-Pasing MVZ GmbH
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Hodgkin lymphoma1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Christian Buske3 trials
- AstraZeneca1 trial
- Celgene Corp.1 trial
- Novartis Pharmaceuticals1 trial
- Universitaet Leipzig1 trial
- and 1 more
Running trials
Recruiting
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026